Microviable Therapeutics was selected to present at Anglonordic Life Science Conference 2023, taking place on April 20th in London. Exclusively selected attendees will represent the key drivers of the European life sciences growth sector.
Microviable’s team, represented by Claudio Hidalgo, PhD as CEO and Rafael Permuy, MBA as CBO, will join decision makers at leading and upcoming drug discovery and technology companies from the UK and Nordic regions, together with investment firms throughout Europe.
For more information or to meet with us at the conference please contact us
